BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32718364)

  • 1.
    Zhang Z; Zhou H; Guan M; Zhou X; Liang X; Lv Y; Bai L; Zhang J; Gong P; Liu T; Yi H; Wang J; Zhang L
    Br J Nutr; 2021 May; 125(10):1081-1091. PubMed ID: 32718364
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhang Z; Zhou H; Zhou X; Sun J; Liang X; Lv Y; Bai L; Zhang J; Gong P; Liu T; Yi H; Wang J; Zhang L
    Br J Nutr; 2021 Mar; 125(5):521-529. PubMed ID: 32718371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chin brick tea [Camellia sinensis (L.) Kuntze] on lipid metabolism and inflammation by modulating intestinal flora and bile acids in mice with non-alcoholic fatty liver disease.
    Jin C; Zhou T; Duan Z; Deng Y; Zhang X; Xiao C; He J; He G; Zhou Y; Li S
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116950. PubMed ID: 37506781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential probiotics Lactobacillus casei K11 combined with plant extracts reduce markers of type 2 diabetes mellitus in mice.
    Zhang Z; Bai L; Guan M; Zhou X; Liang X; Lv Y; Yi H; Zhou H; Liu T; Gong P; Sun J; Zhang L
    J Appl Microbiol; 2021 Oct; 131(4):1970-1982. PubMed ID: 33694236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of Lactobacillus casei and Chlorella vulgaris in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD)-associated kidney damages: a stereological study.
    Keyghobadi H; Bozorgpoursavadjani H; Koohpeyma F; Mohammadipoor N; Nemati M; Dehghani F; Jamhiri I; Keighobadi G; Dastghaib S
    Mol Biol Rep; 2024 May; 51(1):613. PubMed ID: 38704764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.
    Chen M; Guo WL; Li QY; Xu JX; Cao YJ; Liu B; Yu XD; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Apr; 11(4):3316-3331. PubMed ID: 32226996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.
    Luo M; Yan J; Wu L; Wu J; Chen Z; Jiang J; Chen Z; He B
    J Immunol Res; 2021; 2021():2264737. PubMed ID: 34458376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
    Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Lee NY; Yoon SJ; Han DH; Gupta H; Youn GS; Shin MJ; Ham YL; Kwak MJ; Kim BY; Yu JS; Lee DY; Park TS; Park SH; Kim BK; Joung HC; Choi IS; Hong JT; Kim DJ; Han SH; Suk KT
    Gut Microbes; 2020 Jul; 11(4):882-899. PubMed ID: 31965894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
    Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
    BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease.
    Jung JH; Kim HS
    Food Chem Toxicol; 2013 Oct; 60():404-12. PubMed ID: 23900008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol-lowering potentials of Lactobacillus strain overexpression of bile salt hydrolase on high cholesterol diet-induced hypercholesterolemic mice.
    Wang G; Huang W; Xia Y; Xiong Z; Ai L
    Food Funct; 2019 Mar; 10(3):1684-1695. PubMed ID: 30839966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
    Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
    Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactobacillus Casei-fermented Amomum Xanthioides Mitigates non-alcoholic fatty liver disease in a high-fat diet mice model.
    Hwang SJ; Choi YJ; Wang JH; Son CG
    Biomed Pharmacother; 2024 Mar; 172():116250. PubMed ID: 38320334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
    Wang W; Shi LP; Shi L; Xu L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
    [No Abstract]   [Full Text] [Related]  

  • 19. Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice.
    Liu B; Zhang J; Sun P; Yi R; Han X; Zhao X
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.
    Chen J; Thomsen M; Vitetta L
    J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.